Recent Material Events - Genta, Inc (GNTA)

Filing Date	Description
2008-08-29	On August 29, 2008, Genta Incorporated (the “Company”) filed a Form S-1 Registration Statement with the Securities and Exchange Commission for the offer and sale of the Company’s common stock. The Form S-1 is not effective and does not ...
2008-08-07	On August 7, 2008, Genta Incorporated issued a press release announcing financial results and corporate highlights for the second quarter and six months ended June 30, 2008. A copy of the press release is furnished as Exhibit 99.1 to this report and ...
2008-06-24	On June 24, 2008, Genta Incorporated, (the Company), announced the presentation of a progress update from an ongoing Phase 3 trial of Genasense® (oblimersen sodium) Injection, the Company’s lead oncology product, in patients with advanced me ...
2008-06-10	On June 5, 2008, Genta Incorporated (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional and accredited investors listed on the signature page thereto, to pl ...
2008-06-06	On June 6, 2008, Genta Incorporated, (the Company), announced that it has submitted an amendment to the Food and Drug Administration (FDA) for its New Drug Application (NDA) for Genasense® (oblimersen sodium) Injection plus chemotherapy for patie ...
2008-06-04	On May 29, 2008, Genta Incorporated, (the Company), announced the results of long-term followup from a Phase 3 trial of the Company’s lead oncology product, Genasense® (oblimersen sodium) Injection, in patients with chronic lymphocytic leuke ...
2008-06-02	On May 27, 2008, Genta Incorporated (the “Company”), entered into an Amendment of its Lease Agreement (the “Amendment”) with The Connell Company, (“Connell”), a corporation based in New Jersey, whereby the lease for one ...
2008-05-08	On May 8, 2008, Genta Incorporated issued a press release announcing financial results and corporate highlights for the quarter ended March 31, 2008. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by r ...
2008-05-07	On May 1, 2008, Genta Incorporated (the “Company”), entered into a Supply Agreement (the “Agreement”) with Avecia Biotechnology, (“Avecia”), a Delaware corporation based in Milford, Massachusetts, whereby Avecia will sup ...
2008-04-15	Grant of Restricted Stock Units to W. Lloyd Sanders, Senior Vice President and Chief Operating Officer and Gary Siegel, Vice President, Finance ...